ID: ALA213706

Max Phase: Preclinical

Molecular Formula: C18H18Cl2N2O2

Molecular Weight: 365.26

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC1(C)CC(NC(=O)Nc2ccc(Cl)cc2)c2cc(Cl)ccc2O1

Standard InChI:  InChI=1S/C18H18Cl2N2O2/c1-18(2)10-15(14-9-12(20)5-8-16(14)24-18)22-17(23)21-13-6-3-11(19)4-7-13/h3-9,15H,10H2,1-2H3,(H2,21,22,23)

Standard InChI Key:  XCNTZWMMYVKZPH-UHFFFAOYSA-N

Associated Targets(Human)

T98G 1524 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Hs 683 377 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus 775804 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

B16-F10 4610 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 365.26Molecular Weight (Monoisotopic): 364.0745AlogP: 5.42#Rotatable Bonds: 2
Polar Surface Area: 50.36Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.49CX Basic pKa: CX LogP: 4.52CX LogD: 4.52
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.75Np Likeness Score: -0.93

References

1. Sebille S, Gall D, de Tullio P, Florence X, Lebrun P, Pirotte B..  (2006)  Design, synthesis, and pharmacological evaluation of R/S-3,4-dihydro-2,2-dimethyl- 6-halo-4-(phenylaminocarbonylamino)-2H-1-benzopyrans: toward tissue-selective pancreatic beta-cell KATP channel openers structurally related to (+/-)-cromakalim.,  49  (15): [PMID:16854075] [10.1021/jm060161z]
2. Khelili S, Florence X, Bouhadja M, Abdelaziz S, Mechouch N, Mohamed Y, de Tullio P, Lebrun P, Pirotte B..  (2008)  Synthesis and activity on rat aorta rings and rat pancreatic beta-cells of ring-opened analogues of benzopyran-type potassium channel activators.,  16  (11): [PMID:18479927] [10.1016/j.bmc.2008.04.043]
3. Goffin E, Lamoral-Theys D, Tajeddine N, de Tullio P, Mondin L, Lefranc F, Gailly P, Rogister B, Kiss R, Pirotte B..  (2012)  N-Aryl-N'-(chroman-4-yl)ureas and thioureas display in vitro anticancer activity and selectivity on apoptosis-resistant glioblastoma cells: screening, synthesis of simplified derivatives, and structure-activity relationship analysis.,  54  [PMID:22809560] [10.1016/j.ejmech.2012.06.050]

Source